COMPARISON OF INHIBITORY AND BACTERICIDAL ACTIVITY OF ANTIPSEUDOMONAL ANTIBIOTICS AGAINST PSEUDOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS

被引:12
作者
ANSORG, R
MULLER, KD
WIORA, J
机构
[1] Institut für Medizinische Mikrobiologie, Universität (GHS) Essen
关键词
Antipseudomonal antibiotics; Minimum bactericidal concentrations; Minimum inhibitory concentrations; Pseudomonas aeruginosa; Susceptibility determination;
D O I
10.1159/000238770
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using a broth microtiter dilution method, the minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of so-called antipseudomonal antibiotics were determined against 79Pseudomonas aeruginosa isolates from cystic fibrosis patients. On the basis of the MIC values and using DIN breakpoints, the percentual susceptibilities led to the following rank order: imipenem (91%), ciprofloxacin (90%), tobramycin (87%), amikacin (87%), ceftazidime (82%), cefsulodin (76%), piperacillin (71%), azlocillin (62%), followed by gentamicin, ceftriaxone, mezlocillin, netilmicin, and cefotaxime (<50%). However, evaluating MBC values according to DIN breakpoints, only ciprofloxacin (82%), tobramycin (77%), amikacin (58%), and imipenem (57%) showed a pronounced antipseudomonal effectiveness. The data indicate that MBC determinations are necessary to evaluate the antibiotic susceptibility ofP. aeruginosa rather than MIC determinations, at least in patients with impaired defence mechanisms which require bactericidal therapy. © 1990 S. Karger AG, Basel.
引用
收藏
页码:222 / 229
页数:8
相关论文
共 24 条
[1]  
ANSORG R, 1980, ZBL BAKT-INT J MED M, V246, P197
[2]   CROSS-RESISTANCE OF PSEUDOMONAS-AERUGINOSA TO CIPROFLOXACIN, EXTENDED-SPECTRUM BETA-LACTAMS, AND AMINOGLYCOSIDES AND SUSCEPTIBILITY TO ANTIBIOTIC COMBINATIONS [J].
CHOW, AW ;
WONG, J ;
BARTLETT, KH ;
SHAFRAN, SD ;
STIVER, HG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1368-1372
[3]  
EDBERG SC, 1984, CUMITECH20 AM SOC MI
[4]  
GEDDES AM, 1980, PSEUDOMONAS AERUGINO, P89
[5]  
GOULD JM, 1985, LANCET, V1, P1224
[7]  
KAYSER FH, 1984, FORTSCHR ANTIMIKROB, V3, P1
[8]   SUSCEPTIBILITY OF 100 BLOOD ISOLATES OF PSEUDOMONAS-AERUGINOSA TO 19 ANTIPSEUDOMONAL ANTIBIOTICS - OLD AND NEW [J].
KORVICK, J ;
YU, VL ;
HILF, M .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 7 (02) :107-111
[9]   INVITRO SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA FROM BACTEREMIC AND FIBROCYSTIC PATIENTS TO 4 QUINOLONES AND 5 OTHER ANTIPSEUDOMONAL ANTIBIOTICS [J].
LESTER, A ;
ANDREASEN, JJ .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (05) :525-529
[10]  
POLLACK M, 1985, PRINCIPLES PRACTICE, P1236